Skip to main content

CRLBF · Cresco Labs Inc. · Documents

Track CRLBF — free
$0.57 -0.02 (-4.11%) At close · Nov 5 Earnings today Play latest call Q3 2026 earnings call transcript
Market Cap
$210.67M
Shares
370.24M
Volume · Nov 5 510K Avg daily vol (3M) 524.97K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $655.85M down 9.5% 40-F filed Mar 6, 2026 Earnings call New Q3 2026 earnings call Held Nov 6, 2026
2026
Nov 3
Current report 6-K
Current report

Cresco Labs shareholders approved creating TopCo, potentially redomiciling it from British Columbia to Delaware, and extending the multiple-voting-share sunset to the third anniversary of a U.S. listing. Each matter received at least 94% approval.

Oct 13
Current report 6-K
Current report

Cresco Labs Inc.’s October 30, 2026 shareholder meeting has approximately 73% Multiple Voting Shares, 26% Subordinate Voting Shares, 1% Proportionate Voting Shares, and 0.0001% Special Subordinate Voting Shares. Affected securities vote separately on minority approval; existing proxies remain valid.

Sep 30
Current report 6-K
Current report

Cresco Labs Inc. shareholders will vote on October 30, 2026 on creating TopCo, exchanging Cresco securities for TopCo shares through a reverse split, redomiciling to Delaware, extending the Multiple Voting Shares’ listing sunset; the board recommends all resolutions.

Read from the first part of this long document
Mar 6
Annual report 40-F FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $655.85M ▼ 9.5% Net loss $135.41M Diluted EPS -$0.38
2025
Mar 14
Annual report 40-F FY2024, ended Dec 31
Annual report for FY2024
Revenue $724.34M ▼ 6.0% Net loss $74.44M Diluted EPS -$0.22
2024
Mar 18
Annual report 40-F FY2023, ended Dec 31
Annual report for FY2023
Revenue $770.89M ▼ 8.5% Net loss $175.52M Diluted EPS -$0.54
2023
Mar 22
Annual report 40-F FY2022, ended Dec 31
Annual report for FY2022
Revenue $842.68M ▲ 2.6% Net loss $212.05M Diluted EPS -$0.71
2022
Showing 1–50 of 64 documents
Key facts CIK 1832928 CUSIP 22587M106 13F (30d) 4 filings 4 filers Visit website Investor relations